昭衍新药
港股通 官网
( 06127.hk)
市盈率876.43市净率0.79市销率2.93股息率1.85%上市时间2021-02-26股价9.37港币 (-0.32% , 494.34万港币) 市值70.23亿港币总股本7.49亿上市至今年化投资收益率-35.30%港股通持仓占H股比例36.02%
所属三级行业生物技术 (恒生) 市盈率-50.43市净率2.80市销率5.25股息率0.62%
所属指数指数纳入纳出
同股同权查看历史折扣
备注 (3): 双击编辑备注
发表讨论

昭衍新药(06127) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1張帆Independent Non Executive Director - A/F2021-02-26--
2歐小傑Independent Non Executive Director2019-01-01--
3孫明成Independent Non Executive Director2019-01-01--
4孫雲霞Executive Director2019-01-01--
5姚大林Executive Director2019-01-01--
6翟永功Independent Non Executive Director2019-01-01--
7高大鵬Executive Director2013-10-01--
8左從林Executive Director2012-12-01--
9顧曉磊Non Executive Director2012-12-012023-04-27
10馮宇霞Executive DirectorChairman2007-06-01--